Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
6.86
+0.15 (2.24%)
At close: Jan 17, 2025, 4:00 PM
6.93
+0.07 (1.02%)
Pre-market: Jan 21, 2025, 8:33 AM EST
Altimmune Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Altimmune stock have an average target of 19.71, with a low estimate of 12 and a high estimate of 26. The average target predicts an increase of 187.32% from the current stock price of 6.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 7 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +162.39% | Jan 8, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +74.93% | Nov 14, 2024 |
UBS | UBS | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +279.01% | Nov 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +74.93% | Aug 22, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +191.55% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
6.74K
from 426.00K
Decreased by -98.42%
Revenue Next Year
n/a
from 6.74K
EPS This Year
-1.36
from -1.66
EPS Next Year
-1.57
from -1.36
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 21,000 | n/a | n/a | |||
Avg | 6,737 | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -95.1% | - | - | |||
Avg | -98.4% | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.34 | -1.35 | -1.52 | |||
Avg | -1.36 | -1.57 | -1.83 | |||
Low | -1.37 | -1.93 | -2.13 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.